Chiasma, Inc. – NASDAQ:CHMA
Chiasma stock price today
Chiasma stock price yearly change
Chiasma key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -2.39 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 77.96 |
Price/Book | 3.76 |
PEG ratio | 0.06 |
EPS | -1.61 |
Revenue | N/A |
EBITDA | -71.47M |
Income | -89.94M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -2968.35% |
Oper. margin | -2408.65% |
Gross margin | 95.78% |
EBIT margin | -2408.65% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChiasma stock price history
Chiasma stock forecast
Chiasma financial statements
| Jun 2020 | 0 | -21.12M | |
|---|---|---|---|
| Sep 2020 | 142K | -18.45M | -12997.89% |
| Dec 2020 | 964K | -19.80M | -2054.77% |
| Mar 2021 | 1.92M | -30.54M | -1587.73% |
| 2020-11-05 | -0.39 | -0.3 |
|---|---|---|
| 2021-03-04 | -0.35 | -0.32 |
| 2021-05-06 | -0.31 | -0.49 |
| Jun 2020 | 93966000 | 41.98M | 44.68% |
|---|---|---|---|
| Sep 2020 | 194561000 | 84.22M | 43.29% |
| Dec 2020 | 176338000 | 84.55M | 47.95% |
| Mar 2021 | 159535000 | 96.84M | 60.71% |
| Jun 2020 | -16.36M | 21.79M | 24.20M |
|---|---|---|---|
| Sep 2020 | -25.34M | -69.08M | 115.37M |
| Dec 2020 | -21.02M | -36.11M | 29K |
| Mar 2021 | -20.64M | 29.41M | 51K |
Chiasma alternative data
| Aug 2023 | 84 |
|---|---|
| Sep 2023 | 84 |
| Oct 2023 | 84 |
| Nov 2023 | 84 |
| Dec 2023 | 84 |
| Jan 2024 | 84 |
| Feb 2024 | 84 |
| Mar 2024 | 84 |
| Apr 2024 | 84 |
| May 2024 | 84 |
| Jun 2024 | 84 |
| Jul 2024 | 84 |
Chiasma other data
| Period | Buy | Sel |
|---|---|---|
| Jul 2020 | 10000 | 0 |
| Nov 2020 | 145000 | 0 |
| Feb 2021 | 0 | 27981 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | MAMLUK RONI director | Common Stock | 27,981 | $1.85 | $51,765 | ||
Sale | MAMLUK RONI director | Common Stock | 27,981 | $1.85 | $51,765 | ||
Option | MAMLUK RONI director | Stock Option (Right to Buy) | 27,981 | $1.85 | $51,765 | ||
Option | FITZPATRICK MARK J. officer: President | Common Stock | 10,000 | $2.6 | $26,000 | ||
Option | FITZPATRICK MARK J. officer: President | Stock Option (Right to Buy) | 10,000 | $2.6 | $26,000 | ||
Purchase | STACK DAVID M director | Common Stock | 25,000 | $4.27 | $106,850 | ||
Purchase | KANNAN RAJ director, officer: CEO and Pres.. | Common Stock | 120,000 | $4 | $480,480 | ||
Purchase | KANNAN RAJ director, officer: CEO and Pres.. | Common Stock | 10,000 | $4.2 | $42,000 | ||
Sale | MAMLUK RONI director | Common Stock | 82,186 | $3 | $246,558 | ||
Option | MAMLUK RONI director | Common Stock | 82,186 | $3 | $246,558 |
| Patent |
|---|
Grant Utility: Method of treating diseases Filling date: 22 May 2020 Issue date: 6 Jul 2021 |
Application Filling date: 20 Jan 2017 Issue date: 24 Jun 2021 |
Grant Filling date: 20 Oct 2017 Issue date: 4 May 2021 |
Application Filling date: 7 May 2020 Issue date: 18 Mar 2021 |
Application Filling date: 10 Nov 2020 Issue date: 25 Feb 2021 |
Application Filling date: 11 Aug 2020 Issue date: 24 Dec 2020 |
Application Filling date: 22 May 2020 Issue date: 17 Dec 2020 |
Grant Utility: Method of treating diseases Filling date: 27 Dec 2018 Issue date: 30 Jun 2020 |
Grant Filling date: 7 May 2018 Issue date: 16 Jun 2020 |
Application Filling date: 27 Dec 2018 Issue date: 3 Oct 2019 |
| Quarter | Transcript |
|---|---|
| Q4 2020 4 Mar 2021 | Q4 2020 Earnings Call Transcript |
| Q2 2020 11 Aug 2020 | Q2 2020 Earnings Call Transcript |
| Q1 2020 11 May 2020 | Q1 2020 Earnings Call Transcript |
| Q4 2019 17 Mar 2020 | Q4 2019 Earnings Call Transcript |
-
What's the price of Chiasma stock today?
One share of Chiasma stock can currently be purchased for approximately $3.76.
-
When is Chiasma's next earnings date?
Unfortunately, Chiasma's (CHMA) next earnings date is currently unknown.
-
Does Chiasma pay dividends?
No, Chiasma does not pay dividends.
-
What is Chiasma's stock symbol?
Chiasma, Inc. is traded on the NASDAQ under the ticker symbol "CHMA".
-
What is Chiasma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Chiasma?
Shares of Chiasma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Chiasma have?
As Jul 2024, Chiasma employs 84 workers.
-
When Chiasma went public?
Chiasma, Inc. is publicly traded company for more then 10 years since IPO on 16 Jul 2015.
-
What is Chiasma's official website?
The official website for Chiasma is chiasma.com.
-
Where are Chiasma's headquarters?
Chiasma is headquartered at 140 Kendrick Street, Building C East, Needham, MASSACHUSETTS.
-
How can i contact Chiasma?
Chiasma's mailing address is 140 Kendrick Street, Building C East, Needham, MASSACHUSETTS and company can be reached via phone at +1 617 928 5300.
Chiasma company profile:
Chiasma, Inc.
chiasma.comNASDAQ
84
Biotechnology
Healthcare
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
Needham, MASSACHUSETTS 02451
CIK: 0001339469
ISIN: US16706W1027
CUSIP: 16706W102
